Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Probiotica.php on line 2
Probiotica
LE WE PMID CA
Probiotica3400Probiotika

Helicobacter pylori

Inflammatory bowel diseases

Inulin type fructans

Lactobacillus GG

Necrotizing enterocolitis

Neonatology

Oligofructose

Pancreatitis (acute)

Probiotica

2005  
1
Probiotics. Some evidence of their effectiveness.
[16353831] Can Fam Physician 51(): 1487-93 (2005)
2003  
2
Potential uses of probiotics in clinical practice.
[14557292] Clin Microbiol Rev 16(4): 658-72 (2003)
2009  
3
Mechanisms of action of probiotics: recent advances.
[18626975] Inflamm Bowel Dis 15(2): 300-10 (2009)
2008  
4
Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.
[18623173] Inflamm Bowel Dis 14(11): 1585-96 (2008)
2008  
5
2004  
6
Probiotics and the management of inflammatory bowel disease.
[15290926] Inflamm Bowel Dis 10(3): 286-99 (2004)
2005  
7
Prevention of infections by probiotics.
[16473765] J Biosci Bioeng 100(6): 583-92 (2005)
2007  
8
Review article: yeast as probiotics -- Saccharomyces boulardii.
[17767461] Aliment Pharmacol Ther 26(6): 767-78 (2007)
2007  
9
Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children.
[17402990] Aliment Pharmacol Ther 25(8): 871-81 (2007)
2007  
10
Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children.
[17269987] Aliment Pharmacol Ther 25(3): 257-64 (2007)
2006  
11
Review article: prebiotics in the gastrointestinal tract.
[16918875] Aliment Pharmacol Ther 24(5): 701-14 (2006)
2006  
12
Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?
[16611267] Aliment Pharmacol Ther 23(8): 1077-86 (2006)
2005  
13
Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits.
[16167966] Aliment Pharmacol Ther 22(6): 495-512 (2005)
2005  
14
Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.
[16128673] Aliment Pharmacol Ther 22(5): 365-72 (2005)
2002  
15
Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea.
[12182746] Aliment Pharmacol Ther 16(8): 1461-7 (2002)
2002  
16
The role of the gut flora in health and disease, and its modification as therapy.
[12182739] Aliment Pharmacol Ther 16(8): 1383-93 (2002)
2009  
17
Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-analysis of randomized controlled trials.
[19807726] Aliment Pharmacol Ther 30(9): 960-1 (2009)
2010  
18
Probiotic bacteria and intestinal epithelial barrier function.
[20299599] Am J Physiol Gastrointest Liver Physiol 298(6): G807-19 (2010)
2005  
19
Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease.
[15701620] Am J Physiol Gastrointest Liver Physiol 288(3): G417-21 (2005)
2010  
20
Probiotics reduce all-cause mortality and necrotizing enterocolitis: it is time to change practice.
[20403934] Pediatrics 125(5): 1068-70 (2010)
2010  
21
Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates.
[20403939] Pediatrics 125(5): 921-30 (2010)
2010  
22
Use of pre-, pro- and synbiotics in patients with acute pancreatitis: a meta-analysis.
[20712060] World J Gastroenterol 16(31): 3970-8 (2010)
2011  
23
2008  
24
2008  
25
Probiotics: definition, sources, selection, and uses.
[18181724] Clin Infect Dis 46 Suppl 2(-): S58-61; discussion S144-51 (2008)
2008  
26
Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification.
[18181714] Clin Infect Dis 46 Suppl 2(-): S115-8; discussion S144-51 (2008)
2008  
27
2009  
28
Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
[20117346] Gastroenterol Clin Biol 33 Suppl 3(-): S228-34 (2009)
2007  
29
Inulin-type fructans: functional food ingredients.
[17951492] J Nutr 137(11 Suppl): 2493S-2502S (2007)
2008  
30
Clinical use of E. coli Nissle 1917 in inflammatory bowel disease.
[18240278] Inflamm Bowel Dis 14(7): 1012-8 (2008)
2010  
31
Microencapsulation of live probiotic bacteria.
[21030820] J Microbiol Biotechnol 20(10): 1367-77 (2010)
2008  
32
Immunomodulatory effects of probiotics in the intestinal tract.
[18525105] Curr Issues Mol Biol 10(1-2): 37-54 (2008)
2011  
33
Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities.
[21637028] Gut Microbes 2(2): 109-14 (2011)
2011  
34
Is microencapsulation the future of probiotic preparations? The increased efficacy of gastro-protected probiotics.
[21637030] Gut Microbes 2(2): 120-3 (2011)
2010  
35
Safety assessment of probiotics for human use.
[21327023] Gut Microbes 1(3): 164-85 (2010)
2010  
36
Probiotics-host communication: Modulation of signaling pathways in the intestine.
[20672012] Gut Microbes 1(3): 148-63 (2010)
2007  
37
Proposed model: mechanisms of immunomodulation induced by probiotic bacteria.
[17360855] Clin Vaccine Immunol 14(5): 485-92 (2007)
2011  
38
The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept).
[21499799] Genes Nutr 6(3): 261-74 (2011)
2011  
39
Intestinal microbiota in human health and disease: the impact of probiotics.
[21617937] Genes Nutr 6(3): 209-40 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Probiotica.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Probiotica.php on line 92